{"id":473,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","title":{"rendered":"L\u00edmites de evidencia de LL-37: p\u00e9ptido end\u00f3geno, entrega dise\u00f1ada y material de cat\u00e1logo"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">\"LL-37\" puede referirse a un p\u00e9ptido de defensa humano end\u00f3geno, un reactivo de ensayo sint\u00e9tico o un sistema de administraci\u00f3n biol\u00f3gica dise\u00f1ado. Los resultados de una de esas intervenciones no pueden transferirse autom\u00e1ticamente a otra.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Lo que muestra el registro<\/h2><ul class=\"wp-block-list\"><li>La expresi\u00f3n end\u00f3gena no es evidencia de administraci\u00f3n ex\u00f3gena.<\/li><li>Un organismo modificado que expresa LL-37 no es equivalente a un LL-37 sint\u00e9tico aislado.<\/li><li>FDA informa informaci\u00f3n insuficiente sobre seguridad humana y se\u00f1ala preocupaciones sobre inmunogenicidad, tumores reproductivos y espec\u00edficos de tejidos.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png\" alt=\"Cient\u00edfico revisando ensayos bacterianos y datos de investigaci\u00f3n de membranas pept\u00eddicas\" class=\"wp-image-461\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Ilustraci\u00f3n editorial original utilizada para identificar el tema de la investigaci\u00f3n. No representa un lote de cat\u00e1logo, medicamento aprobado, resultado de ensayo o uso cl\u00ednico.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">La frontera entre identidad y evidencia<\/h2><p class=\"wp-block-paragraph\">Un art\u00edculo sobre un microorganismo que expresa LL-37 prueba la intervenci\u00f3n de ingenier\u00eda completa, incluido su sistema de administraci\u00f3n. No debe citarse como si los participantes hubieran recibido un vial de LL-37 aislado.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Contexto end\u00f3geno<\/strong><span>Catelicidina humana en inmunidad innata<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexto del ensayo<\/strong><span>P\u00e9ptido sint\u00e9tico en condiciones in vitro espec\u00edficas.<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexto de seguridad<\/strong><span>FDA identifica importantes lagunas de informaci\u00f3n y preocupaciones no cl\u00ednicas<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Qu\u00e9 pertenece al registro de materiales<\/h2><p class=\"wp-block-paragraph\">Para la caracterizaci\u00f3n de materiales, la confirmaci\u00f3n de secuencia, la pureza, la masa, la agregaci\u00f3n y los controles de endotoxinas o carga biol\u00f3gica responden a diferentes preguntas. Ninguno proporciona una conclusi\u00f3n sobre la eficacia humana.<\/p><h2 class=\"wp-block-heading\">Regla editorial<\/h2><p class=\"wp-block-paragraph\">Utilice el nombre exacto de la intervenci\u00f3n, el modelo, la poblaci\u00f3n y el criterio de valoraci\u00f3n del registro citado. No convierta una asociaci\u00f3n, mecanismo, resultado en animales, registro de medicamento terminado aprobado o prueba anal\u00edtica en una afirmaci\u00f3n sobre un lote de cat\u00e1logo no relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>\"LL-37\" puede referirse a un p\u00e9ptido de defensa humano end\u00f3geno, un reactivo de ensayo sint\u00e9tico o un sistema de administraci\u00f3n biol\u00f3gica dise\u00f1ado. Los resultados de una de esas intervenciones no pueden transferirse autom\u00e1ticamente a otra.<\/p>","protected":false},"author":1,"featured_media":638,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"348","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"In-vitro evidence and current FDA safety assessment","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"LL-37 ocular expression and antimicrobial activity\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16020269\/\",\"note\":\"Human tissue expression and in-vitro assays; PMID 16020269.\"},{\"title\":\"LL-37 analog activity, cytotoxicity and serum inhibition\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15980359\/\",\"note\":\"In-vitro context; PMID 15980359.\"},{\"title\":\"FDA list of bulk substances with significant safety concerns\",\"url\":\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\",\"note\":\"Current FDA LL-37 safety summary.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-473","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>LL-37 Evidence Boundaries: Endogenous vs Engineered<\/title>\n<meta name=\"description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\" \/>\n<meta property=\"og:description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"name\":\"LL-37 Evidence Boundaries: Endogenous vs Engineered\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L\u00edmites de la evidencia LL-37: end\u00f3gena versus dise\u00f1ada","description":"\"LL-37\" puede referirse a un p\u00e9ptido de defensa humano end\u00f3geno, un reactivo de ensayo sint\u00e9tico o un sistema de administraci\u00f3n biol\u00f3gica dise\u00f1ado. Resultados de uno de esos\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_locale":"es_ES","og_type":"article","og_title":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","og_description":"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026","og_url":"https:\/\/nhdbio.com\/es\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","url":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","name":"L\u00edmites de la evidencia LL-37: end\u00f3gena versus dise\u00f1ada","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"\"LL-37\" puede referirse a un p\u00e9ptido de defensa humano end\u00f3geno, un reactivo de ensayo sint\u00e9tico o un sistema de administraci\u00f3n biol\u00f3gica dise\u00f1ado. Resultados de uno de esos\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=473"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/473\/revisions"}],"predecessor-version":[{"id":503,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/473\/revisions\/503"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/638"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}